|
|
Blood, 1 September 2005, Vol. 106, No. 5, pp. 1711-1717.
Prepublished online as a Blood First Edition Paper on May 10, 2005; DOI 10.1182/blood-2005-03-0918.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells
Jérôme D. Coudert,
Jacques Zimmer,
Elena Tomasello,
Marek Cebecauer,
Marco Colonna,
Eric Vivier, and
Werner Held
From the Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Switzerland; the Centre d'Immunologie INSERM/CNRS de Marseille-Luminy, France; and the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO.
NKG2D is an activation receptor that allows natural killer (NK) cells to detect diseased host cells. The engagement of NKG2D with corresponding ligand results in surface modulation of the receptor and reduced function upon subsequent receptor engagement. However, it is not clear whether in addition to modulation the NKG2D receptor complex and/or its signaling capacity is preserved. We show here that the prolonged encounter with tumor cell-bound, but not soluble, ligand can completely uncouple the NKG2D receptor from the intracellular mobilization of calcium and the exertion of cell-mediated cytolysis. However, cytolytic effector function is intact since NKG2D ligand-exposed NK cells can be activated via the Ly49D receptor. While NKG2D-dependent cytotoxicity is impaired, prolonged ligand exposure results in constitutive interferon  (IFN) production, suggesting sustained signaling. The functional changes are associated with a reduced presence of the relevant signal transducing adaptors DNAX-activating protein of 10 kDa (DAP-10) and killer cell activating receptor-associated protein/DNAX-activating protein of 12 kDa (KARAP/DAP-12). That is likely the consequence of constitutive NKG2D engagement and signaling, since NKG2D function and adaptor expression is restored to normal when the stimulating tumor cells are removed. Thus, the chronic exposure to tumor cells expressing NKG2D ligand alters NKG2D signaling and may facilitate the evasion of tumor cells from NK cell reactions. (Blood. 2005;106:1711-1717)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. D. Coudert, L. Scarpellino, F. Gros, E. Vivier, and W. Held
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Blood,
April 1, 2008;
111(7):
3571 - 3578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. I. Marusina, S. J. Burgess, I. Pathmanathan, F. Borrego, and J. E. Coligan
Regulation of Human DAP10 Gene Expression in NK and T Cells by Ap-1 Transcription Factors
J. Immunol.,
January 1, 2008;
180(1):
409 - 417.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Elsner, V. Muppala, M. Gehrmann, J. Lozano, D. Malzahn, H. Bickeboller, E. Brunner, M. Zientkowska, T. Herrmann, L. Walter, et al.
The Heat Shock Protein HSP70 Promotes Mouse NK Cell Activity against Tumors That Express Inducible NKG2D Ligands
J. Immunol.,
October 15, 2007;
179(8):
5523 - 5533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Porcu-Buisson, M. Lambert, L. Lyonnet, A. Loundou, M. Gamerre, L. Camoin-Jau, F. Dignat-George, S. Caillat-Zucman, and P. Paul
Soluble MHC Class I chain-related molecule serum levels are predictive markers of implantation failure and successful term pregnancies following IVF
Hum. Reprod.,
August 1, 2007;
22(8):
2261 - 2266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Roda-Navarro and H. T. Reyburn
Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance
FASEB J,
June 1, 2007;
21(8):
1636 - 1646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Osaki, H. Saito, T. Yoshikawa, S. Matsumoto, S. Tatebe, S. Tsujitani, and M. Ikeguchi
Decreased NKG2D Expression on CD8+ T Cell Is Involved in Immune Evasion in Patients with Gastric Cancer
Clin. Cancer Res.,
January 15, 2007;
13(2):
382 - 387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Ralainirina, A. Poli, T. Michel, L. Poos, E. Andres, F. Hentges, and J. Zimmer
Control of NK cell functions by CD4+CD25+ regulatory T cells
J. Leukoc. Biol.,
January 1, 2007;
81(1):
144 - 153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Roda-Navarro, M. Vales-Gomez, S. E. Chisholm, and H. T. Reyburn
Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function
PNAS,
July 25, 2006;
103(30):
11258 - 11263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Chen, T. Uno, and B. R. Ksander
Tumor Escape Mutants Develop within an Immune-Privileged Environment in the Absence of T Cell Selection
J. Immunol.,
July 1, 2006;
177(1):
162 - 168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gasser and D. H. Raulet
The DNA damage response arouses the immune system.
Cancer Res.,
April 15, 2006;
66(8):
3959 - 3962.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Boissel, D. Rea, V. Tieng, N. Dulphy, M. Brun, J.-M. Cayuela, P. Rousselot, R. Tamouza, P. Le Bouteiller, F.-X. Mahon, et al.
BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.
J. Immunol.,
April 15, 2006;
176(8):
5108 - 5116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jewett, N. A. Cacalano, C. Head, and A. Teruel
Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
Clin. Cancer Res.,
April 1, 2006;
12(7 Pt 1):
1994 - 2003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hoglund
DNA Damage and Tumor Surveillance: One Trigger for Two Pathways
Sci. Signal.,
January 10, 2006;
2006(317):
pe2 - pe2.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
